Rare diseases
Investigational molecules
Locations
Back to Slovakia7 clinical trials in Lubochna, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SlovakiaKlinickeSkusky.sk(opens in a new tab)SlovakiaA Study of Zenagamtide in Adults With Overweight or Obesity and Type 2 Diabetes
SlovakiaA study on the effectiveness of cagrilintide and semaglutide for weight management in children and adolescents with obesity
SlovakiaStudy of Debio 4126, a new octreotide formulation, compared to placebo in patients with acromegaly who were previously treated with somatostatin analogs
SlovakiaStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
SlovakiaA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
SlovakiaEvaluating Once Daily Orforglipron (LY3502970) Compared to Insulin Glargine in Adults with Type 2 Diabetes and Obesity or Overweight who Have Increased Cardiovascular Risk
SlovakiaThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on heart failure prevention through combination therapy studies, examining new approaches to reduce cardiovascular events and improve patient outcomes.
These trials aim to evaluate novel therapeutic combinations for enhanced cardiovascular protection.
Advanced clinical research investigating atherosclerotic cardiovascular disease prevention, with emphasis on reducing major adverse cardiovascular events in high-risk populations.
Studies focus on innovative treatments to prevent strokes, heart attacks, and other cardiovascular complications.
Comprehensive studies addressing multiple aspects of metabolic health, including Type 2 Diabetes and obesity management, with particular attention to cardiovascular risk factors.
These trials evaluate new therapeutic approaches for patients with complex metabolic conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
